Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Florida Health Center COVID-19 Survey Summary Report

Florida Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 41 (87% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 6,546
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 73.47%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 1,101
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 59.31%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 24.64% 37.51%
White, Hispanic/Latino Patients 27.67% 22.07%
Black/African American, Non-Hispanic/Latino Patients 29.06% 23.16%
Black/African American, Hispanic/Latino Patients 1.24% 1.54%
Asian Patients3 1.18% 1.27%
American Indian/Alaska Native Patients3 0.52% 0.73%
Native Hawaiian/Other Pacific Islander Patients3 0.64% 0.54%
Patients with More Than One Race3 3.27% 2.09%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.66% 3.27%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.57% 1.63%
Unreported/Refused to Report Race and Ethnicity 5.56% 6.18%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 376
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 83.19%
COVID-19 Immunization Series Completed 350
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 87.10%
COVID-19 Immunization Series Additional 623
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 77.53%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 15.96% 12.57% 21.35%
White, Hispanic/Latino Patients 33.24% 31.43% 32.26%
Black/African American, Non-Hispanic/Latino Patients 28.46% 34.00% 27.13%
Black/African American, Hispanic/Latino Patients 1.60% 2.29% 2.09%
Asian Patients3 2.13% 2.86% 3.37%
American Indian/Alaska Native Patients3 0.80% 0.86% 0.48%
Native Hawaiian/Other Pacific Islander Patients3 0.27% 0.57% 0.80%
Patients with More Than One Race3 7.45% 6.57% 3.37%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.05% 6.29% 4.17%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.33% 1.14% 0.48%
Unreported/Refused to Report Race and Ethnicity 3.72% 1.43% 4.49%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 34.15%
1 to 24 Hours 19.51%
More Than 24 Hours 46.34%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 2.44%
Staffing to administer the vaccine 9.76%
Vaccine confidence 46.34%
Vaccine storage capacity 0.00%
Vaccine supply 2.44%
Other 9.76%
None 36.59%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 51.22%
Average Percent of Health Center Visits Conducted Virtually 15.61%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 31.71%
Number of Mobile Van Sites 13
Number of Pop-up Clinics 24
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 12

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 12.20%
Refer patients to another organization that provides monoclonal antibody therapies 29.27%
None 58.54%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 12.20%
Patient awareness/education 2.44%
Staffing capacity 26.83%
Therapy administration/onsite logistics 21.95%
Other 12.20%
None 41.46%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 30
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 6,234

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 90.00%
Provided to General Public Who Came to the Health Center 50.00%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 16.67%
Provided at Other Community Events 26.67%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 13.33%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 20.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 3.33%
Provided to school-age children and/or their families directly or through partnerships with schools 6.67%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 10.00%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 22
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 14,879

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 86.36%
Provided to General Public Who Came to the Health Center 45.45%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 18.18%
Provided at Other Community Events 27.27%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 13.64%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 22.73%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 13.64%
Provided to school-age children and/or their families directly or through partnerships with schools 0.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 9.09%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 12
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 51.89%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 40.57%
White, Hispanic/Latino Patients 36.79%
Black/African American, Non-Hispanic/Latino Patients 4.72%
Black/African American, Hispanic/Latino Patients 1.89%
Asian Patients3 2.83%
American Indian/Alaska Native Patients3 0.94%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 1.89%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.83%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.89%
Unreported/Refused to Report Race and Ethnicity 5.66%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 4.72%
Patients Experiencing Homelessness 2.83%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 25.47%
Children Under 18 Years of Age 17.92%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: